U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
LINTUZUMAB SATETRAXETAN AC-225
Common Name English
ACTINIUM (225AC) LINTUZUMAB SATETRAXETAN
INN  
Preferred Name English
HUM-195 AC-225
Common Name English
225AC-LINTUZUMAB
Common Name English
SGN-33 AC-225
Code English
ACTINIUM AC-225 LINTUZUMAB
Common Name English
225AC-HUM195
Common Name English
Actinium (225Ac) lintuzumab satetraxetan [WHO-DD]
Common Name English
actinium (²²?Ac) lintuzumab satetraxetan [INN]
Common Name English
LINTUZUMAB ACTINIUM AC-225
Common Name English
ACTIMAB-A
Brand Name English
ACTINIUM AC 225 LINTUZUMAB
Common Name English
ACTINIUM-225-LABELED HUMANIZED ANTI-CD33 MONOCLONAL ANTIBODY HUM195
Common Name English
Classification Tree Code System Code
EU-Orphan Drug EU/3/17/1871
Created by admin on Tue Apr 01 20:37:44 GMT 2025 , Edited by admin on Tue Apr 01 20:37:44 GMT 2025
FDA ORPHAN DRUG 451714
Created by admin on Tue Apr 01 20:37:44 GMT 2025 , Edited by admin on Tue Apr 01 20:37:44 GMT 2025
NCI_THESAURUS C1511
Created by admin on Tue Apr 01 20:37:44 GMT 2025 , Edited by admin on Tue Apr 01 20:37:44 GMT 2025
Code System Code Type Description
DRUG BANK
DB15053
Created by admin on Tue Apr 01 20:37:44 GMT 2025 , Edited by admin on Tue Apr 01 20:37:44 GMT 2025
PRIMARY
INN
11089
Created by admin on Tue Apr 01 20:37:44 GMT 2025 , Edited by admin on Tue Apr 01 20:37:44 GMT 2025
PRIMARY
SMS_ID
300000038098
Created by admin on Tue Apr 01 20:37:44 GMT 2025 , Edited by admin on Tue Apr 01 20:37:44 GMT 2025
PRIMARY
NCI_THESAURUS
C82414
Created by admin on Tue Apr 01 20:37:44 GMT 2025 , Edited by admin on Tue Apr 01 20:37:44 GMT 2025
PRIMARY
CAS
2209911-94-2
Created by admin on Tue Apr 01 20:37:44 GMT 2025 , Edited by admin on Tue Apr 01 20:37:44 GMT 2025
PRIMARY
FDA UNII
V860J30J9N
Created by admin on Tue Apr 01 20:37:44 GMT 2025 , Edited by admin on Tue Apr 01 20:37:44 GMT 2025
PRIMARY
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966